Atlas Trials

AIM Vaccine Co., Ltd.

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch AIM Vaccine Co., Ltd.

RecordFirmDate
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) (NCT05939648)AIM Vaccine Co., Ltd.2023-10-09
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) (NCT05939596)AIM Vaccine Co., Ltd.2023-08-10
Clinical Trial of SARS-CoV-2 mRNA Vaccine(LVRNA009) as Heterologous Booster in Islamabad (NCT05428592)AIM Vaccine Co., Ltd.2023-04-01
A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People (NCT05549206)AIM Vaccine Co., Ltd.2023-04-01
Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older (NCT05812014)AIM Vaccine Co., Ltd.2023-03-25
Clinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants (NCT05599802)AIM Vaccine Co., Ltd.2023-02-01
A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19 (NCT05682638)AIM Vaccine Co., Ltd.2023-01-30
Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over (NCT05745545)AIM Vaccine Co., Ltd.2023-01-04
A Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China (NCT05547243)AIM Vaccine Co., Ltd.2022-09-26
A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China (NCT05550142)AIM Vaccine Co., Ltd.2022-09-16
A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China (NCT05547256)AIM Vaccine Co., Ltd.2022-09-13
Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People (NCT05352867)AIM Vaccine Co., Ltd.2022-03-16
Clinical Trial of SARS-CoV-2 mRNA Vaccine in China (NCT05364047)AIM Vaccine Co., Ltd.2021-07-31

Track AIM Vaccine Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.